Menu

• Ask a Health Expert about GRAFT VERSUS HOST DISEASE
• Post Your Side Effect related to GRAFT VERSUS HOST DISEASE
• GRAFT VERSUS HOST DISEASE and FDA Warnings
• GRAFT VERSUS HOST DISEASE in Patients Wiki
• Report GRAFT VERSUS HOST DISEASE in Drug Side Effect Survey

GRAFT VERSUS HOST DISEASE side effect

What is GRAFT VERSUS HOST DISEASE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Mab Side Effects Report #5657043-X
Consumer or non-health professional from MEXICO reported MAB CAMPATH problem on Feb 18, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, antifungal prophylaxis, antiviral prophylaxis, prophylaxis against graft versus host disease and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR, ITRACONAZOLE, METHOTREXATE. Patient died.

Mab Side Effects Report #5657075-1
MAB CAMPATH problem was reported by a Consumer or non-health professional from MEXICO on Feb 19, 2008. Male patient, 53 years of age, was diagnosed with acute graft versus host disease, pneumocystis jiroveci infection, antifungal prophylaxis, antiviral prophylaxis and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR. Patient died.

Mab Side Effects Report #5661796-4
Consumer or non-health professional from MEXICO reported MAB CAMPATH problem on Feb 19, 2008. Male patient, 53 years of age, was diagnosed with acute graft versus host disease, pneumocystis jiroveci infection, antifungal prophylaxis, antiviral prophylaxis and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR. Patient died.

Prednisone Side Effects Report #5678666-8
PREDNISONE problem was reported by a Health Professional from CANADA on Mar 10, 2008. Female patient, 44 years of age, weighting 215.6 lb, was diagnosed with infection prophylaxis and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes simplex, lobar pneumonia, mucosal inflammation, . PREDNISONE dosage: unknown. During the same period patient was treated with VORICONAZOLE, MYCOPHENOLATE MOFETIL, TACROLIMUS, RABEPRAZOLE, ACYCLOVIR, NIFEDIPINE, MAGNESIUM, RESTAS. Patient was hospitalized. Patient recovered.


Busulfan Side Effects Report #5679929-2
Consumer or non-health professional from CANADA reported BUSULFAN problem on Mar 13, 2008. Female patient was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . BUSULFAN dosage: 3.2 MG/KG; X1; IV. During the same period patient was treated with FLUDARABINE. Patient died.

Busulfan Side Effects Report #5679930-9
BUSULFAN problem was reported by a Consumer or non-health professional from CANADA on Mar 13, 2008. Female patient was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . BUSULFAN dosage: 3.2 MG/KG; X1; IV. During the same period patient was treated with FLUDARABINE. Patient died.

Alemtuzumab Side Effects Report #5627853-3
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Male patient, 33 years of age, was diagnosed with graft versus host disease, stem cell transplant, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARA, CYCLOSPORINE, CORTICOSTEROIDS, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.

Alemtuzumab Side Effects Report #5629376-4
ALEMTUZUMAB problem was reported by a Health Professional from MEXICO on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, SULFAMETHOXAZOLE, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.

Alemtuzumab Side Effects Report #5629378-8
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.


Alemtuzumab Side Effects Report #5631876-8
ALEMTUZUMAB problem was reported by a Health Professional from MEXICO on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, SULFAMETHOXAZOLE, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.

Alemtuzumab Side Effects Report #5631877-X
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Female patient, 27 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.

Rituximab Side Effects Report #5593996-6
RITUXIMAB problem was reported by a Physician from FRANCE on Jan 16, 2008. Male patient was diagnosed with chronic lymphocytic leukaemia, infection, cytomegalovirus infection and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . RITUXIMAB dosage: 375 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, AMIKLIN, CYMEVAN. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5628265-9
Health Professional from UNITED STATES reported REVLIMID problem on Nov 20, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient recovered.

Prograf Side Effects Report #5542809-7
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 27, 2007. Male patient, 36 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, MYCOPHENOLATE MOFETIL, HYDROXYCHLOROQUINE SULPHATE. Patient recovered.


Cyclosporine Side Effects Report #5549520-7
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Dec 05, 2007. Female patient, 57 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kidney transplant rejection, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with SIMULECT, MIZORIBINE, PREDNISOLONE. Patient recovered.

Cyclosporine Side Effects Report #5550505-5
CYCLOSPORINE problem was reported by a Physician from UNITED STATES on Nov 26, 2007. Male patient, 67 years of age, was diagnosed with liver transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kaposi's sarcoma, meningitis, nosocomial infection, pneumonia, pseudomembranous colitis, respiratory failure, sepsis, . CYCLOSPORINE dosage: unknown. Patient was hospitalized. Patient died.

Cyclophosphamide Side Effects Report #5554439-1
Health Professional from GREECE reported CYCLOPHOSPHAMIDE problem on Dec 10, 2007. Female patient, 28 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, hormone level abnormal, ovarian failure, uterine haemorrhage, vaginal disorder, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOSPORINE. Patient recovered.

Imuran Side Effects Report #5574384-5
IMURAN problem was reported by a Health Professional from UNITED STATES on Dec 11, 2007. Male patient, child 11 years of age, weighting 75.00 lb, was diagnosed with immunosuppression, growth hormone deficiency and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, squamous cell carcinoma, . IMURAN dosage: 50 MG;QOD;PO. During the same period patient was treated with PROGRAF, SAIZEN, VFEND, ACYCLOVIR, CORTEF, LEVAQUIN, PREDNISONE. Patient recovered.

Prograf Side Effects Report #5509953-1
Physician from JAPAN reported PROGRAF problem on Oct 24, 2007. Female patient, 48 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, histiocytosis haematophagic, no therapeutic response, serum ferritin increased, . PROGRAF dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE. Patient died.


Prograf Side Effects Report #5515363-3
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 55 years of age, was diagnosed with liver transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, infection, pleural effusion, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, BACTRIM, ACTIGALL, BUMEX, PEPCID, FLEXERIL, NORCO. Patient was hospitalized. Patient died on 06/05/2007.

Prograf Side Effects Report #5525659-7
Physician from UNITED STATES reported PROGRAF problem on Nov 12, 2007. Female patient, 16 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes sepsis, herpes simplex, oral herpes, pancytopenia, pneumonia herpes viral, respiratory failure, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient died.

Daunorubicin Side Effects Report #5533357-9
DAUNORUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with DAUNORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes virus infection, lip and/or oral cavity cancer, stem cell transplant, . DAUNORUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ETOPOSIDE, FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOPHOSPHAMIDE, TACROLIMUS, MYCOPHENOLATE MOFETIL, METHOTREXATE. Patient recovered.

Prograf Side Effects Report #5477633-7
Physician from JAPAN reported PROGRAF problem on Sept 20, 2007. Male patient, 41 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, non-hodgkin's lymphoma recurrent, thrombotic microangiopathy, . PROGRAF dosage: 0.03 MG/LG, /D. During the same period patient was treated with METHOTREXATE, PREDNISONE, MYCOPHENOLATE MOFETIL. Patient recovered.

Cyclophosphamide Side Effects Report #5484112-X
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.

Cyclophosphamide Side Effects Report #5484113-1
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.

Fludara Side Effects Report #5484114-3
FLUDARA problem was reported by a Physician from UNITED STATES on Oct 02, 2007. Female patient was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . FLUDARA dosage: 25 MG/M2 DAYS -6 TO -2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DONOR LYMPHOCYTE INFUSION. Patient was hospitalized. Patient died.

Cyclophosphamide Side Effects Report #5484115-5
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.

Cyclophosphamide Side Effects Report #5484116-7
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Female patient was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphopenia, neutropenia, . CYCLOPHOSPHAMIDE dosage: 50 MG/KG DAY -6 ONE DOSE. During the same period patient was treated with DONOR LYMPHOCYTE INFUSION, FLUDARA. Patient was hospitalized. Patient died.

Rituximab Side Effects Report #5492595-4
Physician from FRANCE reported RITUXIMAB problem on Jan 02, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia, infection, cytomegalovirus infection and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . RITUXIMAB dosage: 375 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, AMIKLIN, CYMEVAN. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5500941-8
EXJADE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . EXJADE dosage: 3000 MG, QD. Patient died.

Cyclophosphamide Side Effects Report #5458620-1
Health Professional from AUSTRIA reported CYCLOPHOSPHAMIDE problem on Sept 17, 2007. Male patient, 54 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, septic shock, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TRANSFUSION. Patient died.

Cyclophosphamide Side Effects Report #5465810-0
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from AUSTRIA on Sept 21, 2007. Male patient, 54 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, septic shock, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TRANSFUSION. Patient died.

Caspofungin Side Effects Report #5470935-X
Consumer or non-health professional from UNITED STATES reported CASPOFUNGIN MSD problem on Sept 19, 2007. Female patient, 63 years of age, was diagnosed with fungal infection and was treated with CASPOFUNGIN MSD. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, multi-organ failure, . CASPOFUNGIN MSD dosage: unknown. During the same period patient was treated with CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, VORICONAZOLE. Patient was hospitalized. Patient died.

Cyclosporine Side Effects Report #5409312-6
CYCLOSPORINE problem was reported by a Consumer or non-health professional from BRAZIL on July 26, 2007. Male patient, 67 years of age, was diagnosed with immunosuppression and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kaposi's sarcoma, leukopenia, meningitis cryptococcal, nosocomial infection, pneumonia, pseudomembranous colitis, rash maculo-papular, respiratory failure, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient died.

Prograf Side Effects Report #5409827-0
Physician from JAPAN reported PROGRAF problem on July 25, 2007. Female patient, 41 years of age, was diagnosed with myasthenia gravis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, malignant neoplasm progression, metastasis, respiratory failure, thymoma, thymoma malignant recurrent, . PROGRAF dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with MYTELASE, PREDNISOLONE, ATROPINE SULPHATE, GASTERLET, SELBEX, BIOFERMIN. Patient died on 12/29/2005.

Pentostatin Side Effects Report #5413327-1
PENTOSTATIN problem was reported by a Health Professional from UNITED STATES on Aug 06, 2007. Male patient, weighting 140.9 lb, was diagnosed with graft versus host disease and was treated with PENTOSTATIN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, pain, . PENTOSTATIN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5419995-2
Physician from JAPAN reported PROGRAF problem on Aug 02, 2007. Female patient, 41 years of age, was diagnosed with myasthenia gravis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, malignant neoplasm progression, metastases to abdominal cavity, metastasis, respiratory failure, thymoma malignant recurrent, . PROGRAF dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with MYTELASE, PREDNISOLONE, ATROPINE SULPHATE, GASTERLET, SELBEX, BIOFERMIN. Patient died on 12/29/2005.

Velcade Side Effects Report #5429438-0
VELCADE problem was reported by a Physician from JAPAN on Aug 13, 2007. Male patient, 50 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, neutrophil count decreased, platelet count decreased, white blood cell count decreased, . VELCADE dosage: 2.00 MG, INTRAVENOUS; 1.60 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, NEORAL, DIFLUCAN, BAKTAR, AMLODIPINE BESYLATE, PERINDOPRIL ERBUMINE, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5440570-8
Consumer or non-health professional from BRAZIL reported CYCLOSPORINE problem on Aug 28, 2007. Male patient, 67 years of age, was diagnosed with immunosuppression and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, kaposi's sarcoma, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient died.

Methotrexate Side Effects Report #5383291-2
METHOTREXATE problem was reported by a Consumer or non-health professional from ITALY on June 20, 2007. Female patient, child 9 years of age, was diagnosed with prophylaxis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, miller fisher syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient recovered.

Dexamethasone Side Effects Report #5383606-5
Consumer or non-health professional from JAPAN reported DEXAMETHASONE problem on June 20, 2007. Female patient, 15 years of age, was diagnosed with rhabdomyosarcoma and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, leukopenia, myelodysplastic syndrome, neutropenia, pulmonary fibrosis, thrombocytopenia, . DEXAMETHASONE dosage: 40 MG/M[2]/DAILY. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CARBOPLATIN, DACTINOMYCIN. Patient died.

Minims Side Effects Report #5386745-8
MINIMS DEXAMETHASONE PHOSPHATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 04, 2007. Male patient, 57 years of age, was treated with MINIMS DEXAMETHASONE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, somnolence, squamous cell carcinoma, . MINIMS DEXAMETHASONE PHOSPHATE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, THALIDOMIDE. Patient recovered.

Aldurazyme Side Effects Report #5390712-8
Physician from SPAIN reported ALDURAZYME problem on Apr 17, 2007. Female patient, child 5 years of age, weighting 30.86 lb, was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . ALDURAZYME dosage: unknown. During the same period patient was treated with STEROIDS, ANTIBIOTICS, ANTIFUNGALS, DOPAMINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died on 10/18/2006.

Velcade Side Effects Report #5390852-3
VELCADE problem was reported by a Physician from JAPAN on July 02, 2007. Male patient, 50 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, hypoaesthesia, hyponatraemia, neutrophil count decreased, platelet count decreased, skin disorder, stomatitis, white blood cell count decreased, . VELCADE dosage: 2.00 MG, , INTRAVENOUS; 1.60 MG, , INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, NEORAL, DIFLUCAN, SULFAMETHOXAZOLE, AMLODIPINE BESYLATE, PERINDOPRIL ERBUMINE, VINILON. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390954-1
Health Professional from UNITED STATES reported ALDURAZYME problem on Sept 11, 2006. Female patient, child 3 years of age, weighting 31.75 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, respiratory failure, . ALDURAZYME dosage: 0.25 MG/KG QWK IV. Patient died on 09/04/2006.

Thymoglobulin Side Effects Report #5423978-6
THYMOGLOBULIN problem was reported by a Health Professional from UNITED STATES on Aug 30, 2006. Female patient, 44 years of age, weighting 173.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, . THYMOGLOBULIN dosage: 0.5 MG/KG QD IV. Patient was hospitalized. Patient recovered.

Methotrexate Side Effects Report #5383291-2
Consumer or non-health professional from ITALY reported METHOTREXATE problem on June 20, 2007. Female patient, child 9 years of age, was diagnosed with prophylaxis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, miller fisher syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient recovered.

Dexamethasone Side Effects Report #5383606-5
DEXAMETHASONE problem was reported by a Consumer or non-health professional from JAPAN on June 20, 2007. Female patient, 15 years of age, was diagnosed with rhabdomyosarcoma and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, leukopenia, myelodysplastic syndrome, neutropenia, pulmonary fibrosis, thrombocytopenia, . DEXAMETHASONE dosage: 40 MG/M[2]/DAILY. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CARBOPLATIN, DACTINOMYCIN. Patient died.

Minims Side Effects Report #5386745-8
Consumer or non-health professional from UNITED KINGDOM reported MINIMS DEXAMETHASONE PHOSPHATE problem on July 04, 2007. Male patient, 57 years of age, was treated with MINIMS DEXAMETHASONE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, somnolence, squamous cell carcinoma, . MINIMS DEXAMETHASONE PHOSPHATE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, THALIDOMIDE. Patient recovered.

Aldurazyme Side Effects Report #5390712-8
ALDURAZYME problem was reported by a Physician from SPAIN on Apr 17, 2007. Female patient, child 5 years of age, weighting 30.86 lb, was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . ALDURAZYME dosage: unknown. During the same period patient was treated with STEROIDS, ANTIBIOTICS, ANTIFUNGALS, DOPAMINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died on 10/18/2006.

Velcade Side Effects Report #5390852-3
Physician from JAPAN reported VELCADE problem on July 02, 2007. Male patient, 50 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, hypoaesthesia, hyponatraemia, neutrophil count decreased, platelet count decreased, skin disorder, stomatitis, white blood cell count decreased, . VELCADE dosage: 2.00 MG, , INTRAVENOUS; 1.60 MG, , INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, NEORAL, DIFLUCAN, SULFAMETHOXAZOLE, AMLODIPINE BESYLATE, PERINDOPRIL ERBUMINE, VINILON. Patient was hospitalized. Patient recovered.